[Alternative treatment of benign prostatic hypertrophy]

Area of Science:

• Urology
• Minimally Invasive Surgery
• Medical Technology

Context:

• Benign Prostatic Hyperplasia (BPH) management often involves surgical interventions with varying costs and outcomes.
• Current non-surgical BPH treatments present limitations in efficacy, patient comfort, and applicability.
• There is a need for cost-effective, minimally invasive BPH management options suitable for diverse patient needs.

Purpose:

• To evaluate alternative management strategies for benign prostatic hyperplasia (BPH) beyond traditional surgery.
• To compare the benefits and drawbacks of various minimally invasive BPH treatments, including Transurethral Incision of the Prostate (TUI).
• To identify the most effective, economical, and modern alternative to prostate adenoma surgery.

Summary:

• This study retrospectively reviewed BPH management techniques, assessing cost, comfort, and outcomes.
• Transurethral Vaporization of the Prostate (TVP) and Transurethral Resection of the Prostate (TURP) were compared to Transurethral Incision of the Prostate (TUI).
• TUI demonstrated comparable outcomes to TURP, with advantages in cost and minimal bleeding, making it a preferred alternative.

Impact:

• Transurethral Incision of the Prostate (TUI) emerges as a modern, effective, and economical endoscopic alternative to surgery for prostate adenoma.
• The findings support TUI as a viable option for BPH management, potentially improving patient outcomes and reducing healthcare costs.
• This research contributes to the understanding of minimally invasive BPH treatments, guiding clinical practice towards more efficient interventions.